We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Magnifying glass highlighting a yellow capsule among various blue and white pills during drug screening.
Industry Insight

From Hits to Leads: Improving Early Drug Discovery With Better Tools

In this interview, Dr. Iain Yisu Wang from MedChemExpress discusses the growing role of AI, the value of phenotypic screening and how tailored compound libraries are helping researchers keep up with the increasing complexity of drug discovery.
3D illustration of a cancer cell under a microscope, used in cancer risk prediction research.
Industry Insight

AI-Enabled Spatial Proteomics Improves Prediction of Progression to Cancer

We spoke with Castle Bioscience's Dr. Rebecca Critchley-Thorne about AI-enabled spatial proteomics, TissueCypher’s impact on Barrett’s esophagus management and its broader potential for precision oncology.
A researcher in a white lab coat operating a digital tablet, with blue scientific holograms emerging from it.
Industry Insight

Lab of the Future Europe 2025: Transforming Life Science Research

From AI to digital laboratories, discover how new technologies are shaping the future of science at Lab of the Future Europe 2025.
Person scratching forearm, illustrating skin irritation linked to toxic epidermal necrolysis.
Industry Insight

Deep Visual Proteomics Reveals New Drug Targets in Lethal Skin Disease

Learn how scientists mapped the protein landscape of toxic epidermal necrolysis, a lethal skin disease, a lethal skin disease, by applying Deep Visual Proteomics, leading to the use of JAK inhibitors with life-saving results.
A newborn baby in hospital with a nurse leaning over administering treatment in preparation for LNP-mediated gene therapy.
Industry Insight

Building the Next Generation of Genetic Medicines With LNPs

A recent milestone study used the LNP delivery system developed by Acuitas Therapeutics to treat a newborn with urea cycle disorder (UCD) successfully with a personalized CRISPR therapy. We spoke to Dr. Ying Tam, their CSO, to find out more.
Digital drug capsule with circuit patterns releasing glowing particles, symbolizing AI.
Industry Insight

AI and Synthetic Biology: Balancing Innovation With Biosecurity

AI is revolutionizing biotechnology innovation, but industry stakeholders must work together to mitigate its risks. In this article, Adam Clore explores the role of nucleic acid biosecurity screening tools and how they can be improved.
Group of human cells floating on a light green background.
Industry Insight

From Policy to Practice: How Human-Based In Vitro Models Are Reshaping Discovery

Discover how scalable, human-based in vitro models are reshaping discovery pipelines, balancing complexity with reproducibility, and enabling new kinds of experimentation that go beyond the limits of animal research.
Five male and female cell and gene therapy scientists with their arms crossed.
Industry Insight

From Bench to Boardroom: Leading Cell and Gene Therapy Through Uncertainty

In this opinion piece, Dr. Stella Vnook explores how cell and gene therapy leaders are adapting to today’s financial and regulatory headwinds, offering actionable insights into how biotech CEOs are rethinking capital strategy.
Female doctor discussing brain scan results with senior woman during Alzheimer's consultation.
Industry Insight

New Partnership Will Probe the Connection Between Tau Protein and Alzheimer’s

Technology Networks spoke with Nautilus Biotechnology and the Allen Institute about their new agreement to advance Alzheimer’s research through proteoform analysis.
A graphic of four pink balls, covered in cilia-like hair.
Industry Insight

Engineering Immune Responses: Protein Design for the Next Era of Cancer Therapy

Dr. Jamie Spangler gives a vision of how engineered proteins could overcome the toughest challenges in cancer immunotherapy.
Advertisement